Skip to content

Clinical trials

Completed Observational Growth Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Growth Disorders Phase: Observational Status: Completed Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20071
20091
20101
201110
20126
20133
20144
20153
20162
20171
20181
20192
20202
20217
20224
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed53

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck KGaA, Darmstadt, Germany19
Novo Nordisk A/S3
Bina Nusantara University2
Danone Asia Pacific Holdings Pte, Ltd.2
Indonesia University2
Queen Mary University of London2
Aga Khan University1
Biomedical Research Center EPLS1
Boston College1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Growth Disorders53
Malnutrition7
Thinness4
Cachexia3
Anemia2
Child Nutrition Disorders2
Genetic Diseases, Inborn2
Obesity2
Acquired Immunodeficiency Syndrome1
Alcoholism1

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.